Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed May 10, 2013 · 10-Q · 40 days after period end · 0001193125-13-213597
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | -$12.95M | -$12.95M | -$1.42M |
| EPS Diluted | -$0.85 | -$0.85 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 10, 2013 · 40 d after period end
